Related Experiment Video

Updated: Jun 9, 2025

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

35.7K

Pearls & Oy-sters: Breaking Bad CIDP: Recognition of Anti-NF155 Autoimmune Nodopathy in Refractory CIDP

Roopa Sharma1, Nicholas J Bellacicco1, Walter G Husar1

  • 1From the Rutgers New Jersey Medical School (R.S., N.J.B., W.G.H., J.H.P.), Newark; East Orange Veterans Hospital (W.G.H., J.H.P.), NJ; University of Pennsylvania (E.L., M.S.), Philadelphia; and Philadelphia VA Medical Center (E.L.), PA.

Neurology
|October 28, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Anti-Nuclear Antibody Screening Using HEp-2 Cells13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.5K
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

2.6K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117